Letters
Women's health Mental health Pharmacology
Volume 199 - Issue 10

Psychotropic medication in pregnancy

Authors:  Roisin N Worsley, Heather Gilbert and Jayashri Kulkarni

Med J Aust 2013; 199 (10): 661. || doi: 10.5694/mja13.10719
Published online: 18 November 2013
The increasing use of psychotropic medicines has led to a need to understand the safety of antipsychotics in pregnancy.
Download PDF (91 KB)
Share: Share on Blue Sky Share on Facebook Share on LinkedIn Share by email

To the Editor: The report by O’Donnell and colleagues on the increasing rate of mental illness in parents of infants highlights a very important issue and is consistent with overseas studies that suggest there is increasing use of psychotropic medication in pregnancy.1,2

To address the lack of information on the safety of psychotropic medication in pregnancy, particularly the safety of antipsychotics, we have established the National Register of Antipsychotic Medication in Pregnancy. Women are prospectively or retrospectively recruited to the register through referrals from health professionals or self-referral.3 So far, 237 women have consented to join the register. We continue to recruit women taking antipsychotics in pregnancy and pregnant women with mental illness who have elected not to take antipsychotic medication, from all over Australia.

Our data reveal that the women included on the register so far use antipsychotic medication during pregnancy for a wide range of disorders. This includes psychotic disorders (42.5% of those currently on the register), bipolar disorders (42%), depression (10%), anxiety disorders (3.5%), obsessive compulsive disorder (1%), and borderline personality disorder (1%). This is a small but growing dataset, with potential limitations on its interpretability such as potential selection bias in the sample, but it provides some insight into the current use of antipsychotic medications during pregnancy in Australia. With use of antipsychotics expanding beyond psychotic disorders, an increasing incidence of mental illness in new parents,1 and the knowledge that most women with mental illness become mothers,4 there is a growing need to understand the safety of antipsychotics in pregnancy.

Authors

  • Roisin N Worsley1
  • Heather Gilbert1
  • Jayashri Kulkarni1
  • 1. Monash Alfred Psychiatry Research Centre, Monash University, Melbourne, VIC.

Correspondence: roisin.worsley@monash.edu

Competing interests

No relevant disclosures.

References

View this article on Wiley Online Library

More like this

Women's health Perspective 1 September 2026 Open Access

Forty Years in the Making: Reporting on the Co-Creation of a National Roadmap for Birthing on Country Services for the Best Start to Life

Res McCalman, Anneka J. Bowman, Roianne West, Kristie Watego, Jyai Allen, Claire Clack, Sue Kildea, Sue Kruske, Melanie Briggs, Cleone Wellington, Rebecca Coddington, Yu Gao, Isabella Garti, Sascha Kowalenko, Sarah Ireland, Catherine Austin, John D. Boffa, Marah Prior, Kelsie Kahl, Bettina Chaseling, Sarah Khaw, Emily Armstrong, Donna Hartz, Yvette Roe

View more